Dr. Siddiqui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Otsuka Pharmaceutical Development & Commercialization, Inc
508 Carnegie Ctr
Princeton, NJ 08540- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Child Neurology, 2006 - 2009
- Vanderbilt University Medical CenterResidency, Pediatrics, 2004 - 2006
- University of Alabama School of MedicineClass of 2004
Certifications & Licensure
- NY State Medical License 2009 - 2026
- TN State Medical License 2008 - 2016
Publications & Presentations
PubMed
- Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real...Turkoz, I., Daskiran, M., Knight, R., Johnston, K., Siddiqui, U., Correll, C.> ;The International Journal of Neuropsychopharmacology. 2024 Feb 1
- 1 citationsComparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients wi...Ibrahim Turkoz, Joshua Wong, Benjamin Chee, Uzma Siddiqui, R Karl Knight, Ute Richarz, Christoph U Correll> ;Therapeutic Advances in Psychopharmacology. 2023 Jan 1
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: